AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets closed

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
154.80-1.32 (-0.85%)
At close: 4:00PM EST

153.93 -0.87 (-0.56%)
After hours: 6:58PM EST

People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close156.12
Open155.14
Bid153.80 x 100
Ask155.50 x 100
Day's Range153.53 - 156.12
52 Week Range133.64 - 176.85
Volume3,404,875
Avg. Volume4,192,333
Market Cap115.16B
Beta1.52
PE Ratio (TTM)15.50
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad
    Investor's Business Daily5 hours ago

    Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad

    Regeneron and Sanofi argue Amgen's patents covering LDL-buster Repatha are too broad.

  • PR Newswire12 hours ago

    deCODE Study Shows that Variants in the Sequence of the Genome that Contribute to Educational Attainment are Under Negative Selection

    In a study published today, scientists at deCODE genetics use genomic and genealogical data from across the population of Iceland over many decades to show that people who carry sequence variations linked to higher levels of education have fewer children than average. As a result, variations in the sequence of the human genome correlated with more education are becoming rarer in the population over time - that is, they are under negative selection in an evolutionary sense. "These findings are an example of how we can use genomics to shed light on the evolutionary causes and consequences of observed social trends in modern human society," said Kari Stefansson, CEO of deCODE and one of the authors on the paper.

  • Better Buy: Amgen Inc. vs. Celgene Corporation
    Motley Fool15 hours ago

    Better Buy: Amgen Inc. vs. Celgene Corporation

    Amgen has the dividends, while Celgene has the growth. Which biotech stock is the better pick for investors?